TM
TMO
Latest · Mar 28, 2026
Quarter ended Mar 28, 2026 · FY2026 Q1

Thermo Fisher Scientific Inc. stock research

Thermo Fisher Scientific (TMO) Free Cash Flow — Quarter Ended Mar 28, 2026

Revenue was lower than the prior quarter but higher than the same quarter last year. Free cash flow and free cash flow margin improved significantly compared to the year-ago quarter, though both declined from the preceding quarter.

Free cash flow takeaway

A quick read on the company's cash generation and what it means for investors.

Revenue was lower than the prior quarter but higher than the same quarter last year. Free cash flow and free cash flow margin improved significantly compared to the year-ago quarter, though both declined from the preceding quarter.

  • Operating cash flow was higher than the year-ago quarter but lower than the prior quarter. Capital expenditure was slightly higher than a year ago and lower than the prior quarter. Free cash flow margin improved from the year-ago quarter but weakened from the prior quarter.
  • Compared to the prior quarter, revenue, operating cash flow, free cash flow, and free cash flow margin were all lower. Compared to the same quarter one year earlier, revenue, operating cash flow, free cash flow, and free cash flow margin were all higher.

FCF snapshot

Quarterly and TTM cash-flow metrics with the minimum valuation context.

TTM free cash flow

$6.7B

Trailing twelve-month free cash flow.

Quarter free cash flow

$816.0M

Free cash flow in the selected fiscal quarter.

Operating cash flow

$1.2B

Cash generated by operations before capital spending.

CapEx

$376.0M

Capital spending and related asset purchases.

FCF margin

7.4%

The share of revenue converted into free cash flow.

TTM FCF yield

3.4%

TTM FCF divided by market capitalization.

Cash flow trend

A short quarterly history shows whether FCF is scaling with revenue or only spiking for one period.

PeriodRevenueOperating CFCapExFCFFCF margin
2025-06-28$10.9B$1.4B$294.0M$1.1B10.2%
2025-09-27$11.1B$2.2B$404.0M$1.8B16.5%
2025-12-31$12.2B$3.5B$465.0M$3.0B24.5%
2026-03-28$11.0B$1.2B$376.0M$816.0M7.4%

Cash conversion quality

Checks that separate high-quality free cash flow from accounting noise or working-capital timing.

FCF / net income49.4%Shows whether accounting earnings convert into cash.
CapEx / revenue3.4%Lower capital intensity usually supports FCF margin.
Net cash-$39.7BCash and equivalents minus total debt.

Recent events shaping cash flow

Near-term business events that help explain the free cash flow result.

Supportive

Year-over-year free cash flow improvement

Free cash flow and free cash flow margin were higher than the same quarter one year earlier, driven by a higher operating cash flow that more than offset a slightly higher capital expenditure.

The year-over-year improvement in free cash flow margin was the strongest observable driver this quarter.

What the cash flow says

How to interpret the company's free cash flow beyond the headline number.

Operating cash flow was higher than the year-ago quarter but lower than the prior quarter. Capital expenditure was slightly higher than a year ago and lower than the prior quarter. Free cash flow margin improved from the year-ago quarter but weakened from the prior quarter.

Compared to the prior quarter, revenue, operating cash flow, free cash flow, and free cash flow margin were all lower. Compared to the same quarter one year earlier, revenue, operating cash flow, free cash flow, and free cash flow margin were all higher.

Monitor the level of capital expenditure relative to operating cash flow, as it consumed a larger portion of operating cash flow this quarter compared to both the prior quarter and the year-ago quarter.

Valuation context

A cash-flow page should show how much investors are paying for the cash stream, without turning into a full DCF.

Market capitalization$198.9BUsed as the denominator for FCF yield.
TTM FCF yield3.4%TTM free cash flow divided by market capitalization.
EV / TTM FCF35.4xA quick valuation bridge, not a full DCF.

Peer context

Free cash flow quality is easier to read against related public companies.

TM
TMO

Thermo Fisher Scientific Inc.

FCF margin

7.4%

FCF yield

3.4%